MedTrace Logo

Freedom Lumbar Disc in the Treatment of Lumbar Degenerative Disc Disease

NCT00775801 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 300

Last updated 2018-01-23

No results posted yet for this study

Summary

This study will look at the result of using the FLD device as an artificial lumbar disc. The study will compare the safety and effectiveness of the FLD artificial lumbar disc to an already approved artificial lumbar disc.

Conditions

  • Degenerative Disc Disease (DDD)

Interventions

DEVICE

FLD

Artificial lumbar disc

DEVICE

Control

Artificial lumbar disc

Sponsors & Collaborators

  • AxioMed Spine Corporation

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
21 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-09-30
Primary Completion
2018-07-31
Completion
2018-07-31

Countries

  • United States
  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00775801 on ClinicalTrials.gov